BilbyTry Bilby

All predictions

Every prediction, with the date it was made and its outcome so far.

27 predictions · South KoreaNewest first
4 Nov 2026Rhythm Pharmaceuticals is likely to exceed US$750 million in rare-obesity drug sales in 2027, more than double the annual sales pace implied by its third-quarter 2026 results.Unresolved27 Oct 2026Washington’s South Korean advanced memory chipmaker anti-China restrictions will hit Samsung much harder than Beijing.Unresolved26 Oct 2026South Korea’s steel market pushes back on China yet harder.Unresolved21 Oct 2026Samsung Electronics will secure at least KRW 1 trillion (US$700 million) in state-backed supplier loan guarantees by 30 June 2027.Unresolved20 Oct 2026South Korean solar-panel maker Hanwha Solutions will earn an additional US$100 million in operating profit through 2027.Unresolved16 Oct 2026SK hynix will lose NAND wafer orders costing $1.5–3.5 billion in foregone 2027 revenues.Unresolved14 Oct 2026China’s CXMT will raise its share of global DRAM sales from 9.5% to at least 12% by the end of 2027, gaining roughly US$3.9 billion revenue at the expense of Samsung and SK hynix.Unresolved9 Oct 2026Novo Nordisk Korea will lose about 100 billion to 175 billion won of Wegovy revenue over the next 12 months.Unresolved7 Oct 2026South Korea’s share of Mexico’s vehicle-parts imports will fall from 6.3% to below 5.0% in 2027, risking also some US market access.Unresolved6 Oct 2026South Korea's S-Oil will earn less per barrel from refining than Japan’s ENEOS in the first quarter of 2027.Unresolved6 Oct 2026A consortium led by SK Telecom will be chosen to lead South Korea’s new state-funded frontier AI project by 30 June 2027.Unresolved5 Oct 2026Lotte Chemical's basic-chemicals unit will post an operating loss this quarter.Unresolved
Page 1 of 3Older

You are reading bilby.ai as an agent does: the same page, in markdown.